Concentrix CORP (CNXC) Institutional Ownership & 13F Filings (Q2 2026)

CNXC ranks #2273 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

CNXC is a top-conviction position for Groupe Bruxelles Lambert — at 100.0% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in CNXC belongs to BlackRock, Inc., but the position matters far more to Groupe Bruxelles Lambert, who has 100.0% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

UBS Group AG has added to its CNXC position for two straight quarters, increasing it by $55.6M to reach $71.0M today.

Groupe Bruxelles Lambert has trimmed its CNXC position for two straight quarters, cutting it by $302.7M while still holding $62.2M.

CNXC is up 0.3% today, and institutions have been net buyers of $85.4M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

CNXC reported a net loss of $1.3B over the trailing twelve months.

• Not yet profitable — net loss of $1.3B over the trailing twelve months
• Revenue grew 3.9% year over year
• Net income declined year over year, from $244.6M to -$1.3B
• Generated $807.0M in positive operating cash flow
• Current ratio of 1.40x — below the conventional 1.5x liquidity buffer
• Liabilities run 2.92x equity — a highly leveraged balance sheet worth noting